| Trial ID: | L1187 |
| Source ID: | NCT00506454
|
| Associated Drug: |
Lipidose
|
| Title: |
Lipid Infusion in Dialysis Patients With Endotoxemia
|
| Acronym: |
LIPIDOSE
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00506454/results
|
| Conditions: |
Fatigue|End Stage Renal Disease (ESRD)
|
| Interventions: |
DRUG: Lipidose|DRUG: Placebo
|
| Outcome Measures: |
Primary: Reduction in Endotoxin Levels., The number of participants whose post-hemodialysis endotoxin (as measured by Endotoxin Activity Assay (EAA)) was less than their pre-hemodialysis endotoxin., Baseline and at 4 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Sepsicure | Collaborators: The Rogosin Institute
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-08
|
| Completion Date: |
2008-02
|
| Results First Posted: |
2011-08-15
|
| Last Update Posted: |
2011-09-20
|
| Locations: |
Rogosin Manhattan Dialysis Center, New York, New York, 10021, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00506454
|
